Umut Gokhan, Evren Cuneyt, Cansiz Alparslan, Akkus Mustafa, Karamustafalioglu Nesrin
Research, Treatment and Training Center for Alcohol and Substance Dependence (AMATEM), Bakirkoy Training and Research Hospital for Psychiatry Neurology and Neurosurgery, Istanbul, Turkey.
Department of Psychiatry, Siverek State Hospital, Sanliurfa, Turkey.
Indian J Psychiatry. 2017 Jan-Mar;59(1):94-99. doi: 10.4103/psychiatry.IndianJPsychiatry_354_16.
In the literature, the relationship between appetite regulating peptides and alcohol craving is on the debate.
This study aims to investigate serum level of NUCB2/nesfatin-1, which is discovered as appetite-related neuropeptide, in patients with alcohol dependence who were in craving and abstaining phase and to compare with healthy controls.
Research, Treatment, and Training Center for Alcohol and Substance Dependence, (AMATEM) Bakirkoy Training and Research Hospital for Psychiatry Neurology and Neurosurgery, Istanbul, case-control and prospective study design were used.
Chi-square, Mann-Whitney U, paired samples, independent samples - and Pearson correlation tests were used for analysis.
Forty-three patients with alcohol dependence who have been admitted for detoxification and thirty healthy controls were included in the study. The blood samples were drawn after the 1 day of admission and postdetoxification treatment in inpatients who reached to abstinence period and from 30 healthy controls. The Penn Alcohol Craving Scale and the Obsessive Compulsive Drinking Scale were applied to detect craving scores.
Initial serum NUCB2/nesfatin-1 levels in patients were significantly lower than in the healthy control group ( < 0.001). The NUCB2/nesfatin-1 level of initial phase was significantly lower than abstinence phase ( = 0.027). No correlation was found between craving scores and NUCB2/nesfatin-1 level ( > 0.05).
This study is the first that showed significant differences of serum NUCB2/nesfatin-1 level according to different stages of alcohol dependence. Plasma NUCB2/nesfatin-1 levels were lower in highest craving phase and tended to normalize after abstinence. Since we could not find a correlation between craving and NUCB2/nesfatin-1 levels, the increase of NUCB2/nesfatin-1 in abstinence phase might have been resulted from other reasons apart from craving.
在文献中,食欲调节肽与酒精渴望之间的关系存在争议。
本研究旨在调查血清中NUCB2/nesfatin-1的水平,该物质被发现为与食欲相关的神经肽,研究对象为处于渴望期和戒断期的酒精依赖患者,并与健康对照组进行比较。
采用病例对照和前瞻性研究设计,研究地点为伊斯坦布尔巴克尔柯伊精神病学、神经病学和神经外科培训与研究医院酒精和物质依赖研究、治疗与培训中心(AMATEM)。
采用卡方检验、曼-惠特尼U检验、配对样本检验、独立样本检验以及皮尔逊相关检验进行分析。
本研究纳入了43名因戒酒入院的酒精依赖患者和30名健康对照者。对达到戒断期的住院患者在入院第1天和戒断治疗后采集血样,同时采集30名健康对照者的血样。应用宾夕法尼亚酒精渴望量表和强迫性饮酒量表来检测渴望得分。
患者初始血清NUCB2/nesfatin-1水平显著低于健康对照组(<0.001)。初始阶段的NUCB2/nesfatin-1水平显著低于戒断阶段(=0.027)。渴望得分与NUCB2/nesfatin-1水平之间未发现相关性(>0.05)。
本研究首次表明,血清NUCB2/nesfatin-1水平在酒精依赖的不同阶段存在显著差异。血浆NUCB2/nesfatin-1水平在渴望程度最高的阶段较低,戒断后趋于正常。由于我们未发现渴望与NUCB2/nesfatin-1水平之间存在相关性,戒断阶段NUCB2/nesfatin-1的升高可能是由渴望以外的其他原因导致的。